Acorah Software Products - Accounts Production 14.5.601 false true 31 July 2022 1 August 2021 false true No description of principal activity 1 August 2022 31 July 2023 31 July 2023 11477337 Mr Victor Odumosu iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11477337 2022-07-31 11477337 2023-07-31 11477337 2022-08-01 2023-07-31 11477337 frs-core:CurrentFinancialInstruments 2023-07-31 11477337 frs-bus:PrivateLimitedCompanyLtd 2022-08-01 2023-07-31 11477337 frs-bus:FilletedAccounts 2022-08-01 2023-07-31 11477337 frs-bus:Micro-entities 2022-08-01 2023-07-31 11477337 frs-bus:AuditExempt-NoAccountantsReport 2022-08-01 2023-07-31 11477337 frs-bus:Director1 2022-08-01 2023-07-31 11477337 2021-07-31 11477337 2022-07-31 11477337 2021-08-01 2022-07-31 11477337 frs-core:CurrentFinancialInstruments 2022-07-31
Registered number: 11477337
Tvg Pharma Ltd
Unaudited Financial Statements
For The Year Ended 31 July 2023
Balance Sheet
Registered number: 11477337
2023 2022
£ £
Fixed assets 125 968
Current assets 105,077 148,357
Creditors: Amounts Falling Due Within One Year (43,356 ) (27,150 )
NET CURRENT ASSETS 61,721 121,207
TOTAL ASSETS LESS CURRENT LIABILITIES 61,846 122,175
NET ASSETS 61,846 122,175
CAPITAL AND RESERVES 61,846 122,175

Notes

1. General Information
Tvg Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 11477337 . The registered office is 49 Oldham Rise, Medbourne, Milton Keynes, MK5 6GE.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2022: 1)
2 1
For the year ending 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr Victor Odumosu
Director
13/09/2023